^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    CDK8/19 inhibitor

    Related drugs:
    2ms
    ROVER-01: RVU120 Rollover Study (clinicaltrials.gov)
    P2, N=10, Not yet recruiting, Ryvu Therapeutics SA | Initiation date: Aug 2025 --> Dec 2025
    Trial initiation date
    |
    romaciclib (RVU120)